Search

Your search keyword '"Marino, Pietro"' showing total 788 results

Search Constraints

Start Over You searched for: Author "Marino, Pietro" Remove constraint Author: "Marino, Pietro"
788 results on '"Marino, Pietro"'

Search Results

2. Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

3. High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

7. Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

9. PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

10. Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

11. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

15. Data from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

16. Supplementary Table S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

17. Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

18. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

20. POLE exonuclease domain mutations in endometrial carcinoma: a case report

21. Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer

23. Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

25. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

26. Prognostic value of gender and primary tumor location in metastatic colon cancer

28. High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study

29. Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis

30. Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer

31. Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer

32. Additional file 1 of High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

37. Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study

39. The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy

40. Environmental Pollution and Peripheral Artery Disease

41. Measurement of $CP$ asymmetry in $D^0 \to K^0_S K^0_S$ decays

42. Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

43. Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy

44. Measurement of the branching fraction of the ${{B} ^0} {\rightarrow }{{D} ^+_{s}} {{\pi } ^-} $ decay

45. Observation of the $B_s^0 \rightarrow D^{\ast \pm} D^{\mp}$ decay

46. Search for heavy neutral leptons in W+→μ+μ±jet decays

47. Observation of New Resonances Decaying to $J/\psi K^+$+ and $J/\psi \phi$

48. Observation of the $\Lambda^0_b \to \Lambda^+_c K^+ K^- \pi^-$ decay

49. Measurement of CP observables in $B^\pm \to D^{(*)} K^\pm$ and $B^\pm \to D^{(*)} \pi^\pm$ decays using two-body D final states

50. Observation of a New Excited $D^+_s$ Meson in $B^0 \rightarrow D^- D^+ K^+ \pi^-$ Decays

Catalog

Books, media, physical & digital resources